CMS discontinues NARP survey

07/23/2013 | Drug Channels

CMS will discontinue the National Average Retail Price survey, which collects average per-prescription revenues for more than 4,000 generic and brand-name outpatient therapies. However, the agency is unlikely to discontinue the surveys on national average drug acquisition costs or average manufacturer prices, industry expert Adam Fein writes.

View Full Article in:

Drug Channels